IRMD
Iradimed Co
85.80$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +180.9% | -0.7% | +71.0% | +37.3% | -34.3% | -28.3% | +80.5% | -9.8% | -15.2% | +40.0% | -28.3% | – | |
| – | +8.2% | +10.1% | -11.9% | -0.8% | -1.4% | -0.4% | +6.9% | +84.9% | -0.8% | +19.5% | -9.9% | – | |
| – | +3.2% | +14.1% | -3.1% | +3.4% | +4.3% | +25.8% | -11.6% | -8.8% | +4.5% | -1.8% | +18.0% | – | |
| – | – | – | – | +28.2% | -93.2% | -803.8% | – | -74.5% | -1,871.5% | – | -124.3% | – | |
| – | +44.1% | -24.3% | +165.2% | +215.9% | -23.8% | +21.0% | -23.6% | -59.7% | -57.6% | -16.4% | -54.1% | – | |
| – | +44.1% | -24.3% | +165.2% | +215.9% | -23.8% | +28.2% | -27.9% | -55.3% | -67.0% | +12.6% | -5.5% | – | |
| – | – | -39.7% | -76.2% | +0.0% | +0.0% | +13.7% | +0.0% | +0.0% | +295.6% | -70.1% | +0.0% | – | |
| – | +1,277.0% | -85.2% | – | – | – | – | – | – | – | – | – | – | |
| – | +737.1% | +2,961.8% | -75.6% | -2.1% | +26.0% | -5.8% | -0.9% | -2.9% | +396.0% | -76.0% | +7.1% | – | |
| – | +227.1% | -253.6% | – | -6.5% | -83.9% | -471.1% | – | +32.5% | -252.0% | – | -48.1% | – | |
| – | +243.9% | +3.8% | +57.7% | -4.9% | -42.6% | -79.7% | +727.8% | +18.8% | -7.0% | +45.0% | -27.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.